Sandbox/v20

Endocarditis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Infective Endocarditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Diagnosis and Follow-up
Medical Therapy
Intervention
Case Studies
Case #1
Sandbox/v20 On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sandbox/v20
CDC onSandbox/v20
Sandbox/v20 in the news
Blogs on Sandbox/v20
to Hospitals Treating Sandbox/v20
Risk calculators and risk factors for Sandbox/v20

Enterococcal Strains Susceptible to Penicillin, Gentamicin, and Vancomycin

Enterococcus Susceptible to Penicillin, Gentamicin, and Vancomycin Preferred Regimen (Adult) ▸ Ampicillin 2 g IV q4h x 4—6 weeks OR ▸ Penicillin G potassium 3—5 million U/day IV q4h x 4—6 weeks PLUS ▸ Gentamicin 1 mg/kg IV q8h x 4—6 weeks Preferred Regimen (Pediatric) ▸ Ampicillin 2 g IV q4h x 4—6 weeks OR ▸ Penicillin G potassium 3—5 million U/day IV q4h x 4—6 weeks PLUS ▸ Gentamicin 1 mg/kg IV q8h x 4—6 weeks Alternative Regimen (Adult)† ▸ Vancomycin 15 mg/kg IV q12h x 6 weeks PLUS ▸ Gentamicin 1 mg/kg IV q8h x 6 weeks Alternative Regimen (Pediatric)† ▸ Vancomycin 15 mg/kg IV q12h x 6 weeks PLUS ▸ Gentamicin 1 mg/kg IV q8h x 6 weeks

Adult, Age <50 Years† Preferred Regimen ▸ Vancomycin 30–60 mg/kg/day IV q8–12h to achieve serum trough concentrations of 15–20 μg/mL AND ▸ Cefotaxime 8–12 g/day IV q4–6h OR ▸ Ceftriaxone 2 g IV q12h Adult, Age >50 Years Preferred Regimen ▸ Vancomycin 30–60 mg/kg/day IV q8–12h AND ▸ Ampicillin 2 g IV q4h AND ▸ Cefotaxime 8–12 g/day IV q4–6h OR ▸ Ceftriaxone 2 g IV q12h Immunocompromised Preferred Regimen ▸ Vancomycin 30–60 mg/kg/day IV q8–12h AND ▸ Ampicillin 2 g IV q4h AND ▸ Cefepime 2 g IV q8h OR ▸ Meropenem 2 g IV q8h Recurrent Preferred Regimen ▸ Vancomycin 30—60 mg/kg/day IV q8–12h AND ▸ Cefotaxime 8–12 g/day IV q4–6h OR ▸ Ceftriaxone 2 g IV q12h